CMR Surgical surpasses 15,000 surgical procedures on Versius® globally as it raises $165 million to support continued growth
Retrieved on:
Wednesday, September 20, 2023
SoftBank Vision Fund, CE, Royal college, Enterprise, Surgeon, Accreditation, Journal of Minimal Access Surgery, Gleneagles Hospital, Lung lobectomy, Royal, Tencent, Innovation, MAS, Royal Papworth Hospital NHS Foundation Trust, Sindh Institute of Urology & Transplantation, Hospital, Patient, Royal Papworth Hospital, SIUT, Hernia, Growth, CMR, CMR Surgical, LGT, News, BST, Dentistry
The company has recently closed an upsized $165 million (£133 million) fundraising to support continued product innovation and commercial growth in existing and key new markets around the world.
Key Points:
- The company has recently closed an upsized $165 million (£133 million) fundraising to support continued product innovation and commercial growth in existing and key new markets around the world.
- CMR Surgical (CMR or ‘the Company’) – the global surgical robotics business – has today announced that its next-generation Versius® Surgical Robotic System has been used to perform more than 15,000 surgeries globally.
- The surgical cases span more than 130 complex and benign procedure types including colectomies, hernia repairs, hysterectomies, sacrocolpopexies, and lobectomies across seven surgical specialties.
- CMR’s vision is to make MAS universally accessible, rapidly increasing the number of robotic-assisted procedures that take place globally.